Title |
Neuromelanin is an immune stimulator for dendritic cells in vitro
|
---|---|
Published in |
BMC Neuroscience, November 2011
|
DOI | 10.1186/1471-2202-12-116 |
Pubmed ID | |
Authors |
Uwe Oberländer, Katrien Pletinckx, Anja Döhler, Nora Müller, Manfred B Lutz, Thomas Arzberger, Peter Riederer, Manfred Gerlach, Eleni Koutsilieri, Carsten Scheller |
Abstract |
Parkinson's disease (PD) is characterized at the cellular level by a destruction of neuromelanin (NM)-containing dopaminergic cells and a profound reduction in striatal dopamine. It has been shown recently that anti-melanin antibodies are increased in sera of Parkinson patients, suggesting that NM may act as an autoantigen. In this study we tested whether NM is being recognized by dendritic cells (DCs), the major cell type for inducing T- and B-cell responses in vivo. This recognition of NM by DCs is a prerequisite to trigger an adaptive autoimmune response directed against NM-associated structures. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Luxembourg | 1 | 2% |
Unknown | 58 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 20% |
Student > Master | 9 | 15% |
Researcher | 7 | 12% |
Student > Bachelor | 6 | 10% |
Student > Doctoral Student | 5 | 8% |
Other | 10 | 17% |
Unknown | 10 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 14 | 24% |
Medicine and Dentistry | 10 | 17% |
Biochemistry, Genetics and Molecular Biology | 8 | 14% |
Neuroscience | 5 | 8% |
Physics and Astronomy | 2 | 3% |
Other | 9 | 15% |
Unknown | 11 | 19% |